Weight loss and proteinuria

Contributions to Nephrology

Volumn 151, Issue , 2006, Pages 221-229

  Praga, Manuel ^a   Morales, Enrique ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; WEIGHT REDUCTION;

HUMANS; OBESITY; PROTEINURIA; RENIN-ANGIOTENSIN SYSTEM; WEIGHT LOSS;

EID: 33748037727     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000095332     Document Type: Review

References (34)

1. Ruggenenti P, Perna A, Mosconi L, et al: Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. Kidney Int 1998;53: 1209-1216.
2. de Zeeuw D, Remuzzi G, Parving HH, et al: Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004;65:2309-2320.
3. Jafar TH, Stark PC, Schmid CH, et al: Proteinuria as a modifiable risk factor for the progression of non-diabetic renal diseases. Kidney Int 2001;60:1131-1140.
4. Peterson JC, Adler S, Burkart JM, et al: Blood pressure control, proteinuria, and the progression of renal disease: The Modification in Diet in Renal Disease Study. Ann Intern Med 1995;123: 754-762.
5. Praga M, Morales E: Renal damage associated with proteinuria. Kidney Int 2002;62(suppl 82):S42-S46.
6. Kambham N, Markowitz G, Valeri AM, et al: Obesity-related glomerulopathy: An emerging epidemic. Kidney Int 2001;59:1498-1509.
7. Valensi P, Assayag M, Busby M, Paries J, Lormeau B, Attali JR: Microalbuminuria in obese patients with or without hypertension. Int J Obes Relat Metab Disord 1996;20:574-579.
8. Praga M, Hernández E, Morales E, et al: Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 2001;16:1790-1798.
9. Praga M, Morales E, Herrero JC, et al: Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration. Am J Kidney Dis 1999;33: 52-58.
10. Vasquez B, Flock EV, Savage PJ, et al: Sustained reduction of proteinuria in Type 2 (non-insulin dependent) diabetes following diet-induced reduction of hyperglucemia. Diabetologia 1984;26: 127-133.
11. Solerte SB, Fioravanti M, Schifino N, Ferrari E: Effects of diet-therapy on urinary protein excretion, albuminuria and renal hemodynamic function in obese diabetic patients with overt nephropathy. Int J Obes 1989;13:203-211.
12. Saiki A, Nagayama D, Ohhira M, et al: Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy. Int J Obes 2005;29:1115-1120.
13. Fredrickson SK, Fedrro TJ, Schutrumpf AC: Disappearance of microalbuminuria in a patient with type 2 diabetes and the metabolic syndrome in the setting of an intense exercise and dietary program with sustained weight reduction. Diabetes Care 2004;27:1754-1755.
14. Praga M, Hernández E, Andrés A, León M, Ruilope LM, Rodicio JL: Effects of body-weight loss and captopril treatment on proteinuria associated with obesity. Nephron 1995;70:35-41.
15. Morales E, Valero MA, León M, Hernández E, Praga M: Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003;41:319-327.
16. Brolin RE: Bariatric surgery and long-term control of morbid obesity. J Am Med Assoc 2002;288: 2793-2796.
17. Izzedine H, Coupaye M, Reach I, Deray G: Gastric bypass and resolution of proteinuria in an obese diabetic patient. Diabetes Med 2005;22:1761-1762.
18. Soto FC, Higa-Sansone G, Copley JB, et al: Renal failure, glomerulonephritis and morbid obesity: improvement after rapid weight loss following laparoscopic gastric bypass. Obes Surg 2005;15: 137-140.
19. Palomar R, Fernández-Fresnedo G, Domínguez-Díez A, et al: Effects of weight loss alter biliopancreatic diversión on metabolism and cardiovascular profile. Obes Surg 2005;15:794-798.
20. Yanovski SZ, Yanovski JA: Obesity. N Engl J Med 2002;346:591-602.
21. Wadden TA, Berkowitz RI, Womble LG, et al: Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 2005;353:2111-2120.
22. Despres JP, Golay A, Sjöström L: Effects of rimonabant on metabolic risk factors in overweight patients with dyslipemia. N Engl J Med 2005;353:2121-2134.
23. Haffner S, Taegtmeyer H: Epidemic obesity and the metabolic syndrome. Circulation 2003;108: 1541-1545.
24. Verrotti A, Basciani F, de Simone M, Morgese G, Chiarelli F: Serum leptin changes during weight loss in obese diabetic subjects with and without microalbuminuria. Diabetes Nutr Metab 2001;14: 283-287.
25. Wolf G, Hamann A, Han CD, et al: Leptin stimulates proliferation and TGF-β expression in renal glomerular endothelial cells: potential role in glomerulosclerosis. Kidney Int 1999;56:860-872.
26. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE: Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001;12:1211-1217.
27. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y: The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003;14:1480-1486.
28. Gonzalez E, Gutiérrez E, Morales E, et al: Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney. Kidney Int 2005;68:263-270.
29. Hall JE: The kidney, hypertension, and obesity. Hypertension 2003;41:625-633.
30. El-Atat FA, Stas SN, McFarlane SI, Sowers JR: The relationship between hyperinsulinemia, hypertension and progressive renal disease. J Am Soc Nephrol 2004;15:2816-2827.
31. Engeli S, Bohnke J, Gorzelniak K, et al: Weight loss and the renin-angiotensin-aldosterone system. Hypertension 2005;45:356-362.
32. De Paula RB, Da Silva AA, Hall JE: Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration. Hypertension 2004;43:41-47.
33. Ehrhart-Bornstein M, Lamounier-Zepter V, Schraven A, et al: Human adipocytes secrete mineralocorticoid-releasing factors. Proc Natl Acad Sci USA 2003;10:14211-14216.
34. Hostetter TH, Ibrahim HN: Aldosterone in chronic kidney and cardiac disease. J Am Soc Nephrol 2003;14:2395-2401.